Neocrema Adds Contract Development of Active Pharmaceutical Ingredients and New Drug Development as Business Objectives
[Asia Economy Reporter Hwang Yoon-joo] Neocrema held an extraordinary general meeting of shareholders and announced on the 7th that it has added ▲contract development and manufacturing of active pharmaceutical ingredients ▲new drug development and sales ▲development and sales of obesity vaccines to its business objectives.
The company stated, "We have changed our business objectives to diversify our business."
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
